TMCnet News
Reflect Scientific Inc. Receives Its Second Order for Additional Programmable Cooling and Cryogenic Freezing SystemsOREM, Utah --(Business Wire)-- Sept. 20, 2006 -- Reflect Scientific Inc. (OTCBB: RSCF), an industry leader whose business is the manufacture, supply and distribution of laboratory equipment and related supplies to the Life Sciences industry announces that Cryometrix Inc., a wholly owned subsidiary of Reflect Scientific, has received an order from an undisclosed client for units of its programmable cooling and cryogenic freezing systems. The systems will be manufactured for shipment by year-end 2006. "This represents a significant step in the progress of our company as we continue forward with our commitment to create value for our customers and our shareholders," remarked Kim Boyce, president and CEO of Reflect Scientific. Boyce further added, "We have been in discussions with several large companies whose business requires economical freezing systems as those offered by Cryometrix. This purchase order further demonstrates the industry's acceptance of our system. We look forward to announcing more contracts in the near future." About Reflect Scientific Inc. Reflect Scientific provides products for the biotechnology, pharmaceutical, and medical industries and has had consistent year-over-year growth for more than 13 years. Reflect Scientific targets strategic acquisitions that will increase revenue and profits in their primary markets and that will fulfill Reflect's strategic imperative of significant, sustained revenue growth through innovative market need-based products. For information related to the Reflect Scientific, contact Investor Relations: Michael Dancy, 801-746-3570, e-mail: [email protected], or visit: www.reflectscientific.com. Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission. |
